Shared Research logo
  • Home
  • All Companies
    All Companies
    Companies
    Recently viewed
    Browse companies...
  • English
    日本語
  • Log in
  • Sign up
Overview
My Comments
My Notes
Kringle Pharma

Kringle Pharma 4884

クリングルファーマ
Kringle Pharma, Inc.
Recent Updates
2023-05-16
Start of patient enrollment at all sites for Phase III clinical trial of HGF therapy for VFS
2023-05-15
1H FY09/23 flash update
2023-04-28
Announcement of FY2022 grant amount for recombinant human HGF protein for acute SCI under the Orphan Products Development Support Program 
Get in touch
Address:207 Saito Bio Incubator 7-7-15 Saitoasagi, Ibaraki, OSAKA 567-0085, JAPAN
Website:https://www.kringle-pharma.com/en/ir_info/
Summary
Kringle Pharma, Inc. is a late clinical-stage biopharmaceutical company. It was founded as a biotech startup in Osaka in December 2001, and traces its roots back to Osaka University. Kringle’s mission is to develop and commercialize innovative medicines for patients suffering from intractable diseases. Its current research and development focus is on the application of recombinant human hepatocyte growth factor (HGF) to treat patients with these rare diseases worldwide.
Key dates
2021-06-21
Coverage initiation